Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

FCA says ex-Schroders trader admits nine insider dealing offences

Published 15/03/2016, 15:54
© Reuters.  FCA says ex-Schroders trader admits nine insider dealing offences
SDR
-

LONDON (Reuters) - A former stock market trader at Schroders (LON:SDR) Investment Management, has pleaded guilty to nine counts of insider trading spanning nine years, Britain's Financial Conduct Authority said on Tuesday.

Damian Clarke, 40, admitted to dealing in shares on the basis of inside information on company mergers and acquisitions obtained while he worked at Schroders.

"He used this information to place trades using accounts in his own name and that of close family members, in respect of which he had been provided with the account numbers and passwords," the FCA said in a statement.

The total profits made from Clarke's insider dealing amount to at least 155,161 pounds, the FCA said.

The FCA said Clarke had pleaded guilty to seven counts of insider trading on 24 July last year, and pleaded guilty to the remaining two counts on Tuesday in London's Southwark Crown Court.

Clarke, who was initially employed by Schroders as a fund manager's assistant and later became an equities trader, will be sentenced on June 13.

"Insider dealing is a dishonest crime, not a means for city professionals to make money on the side," said Mark Steward, the FCA's director of enforcement.

"Mr Clarke abused the trust that came with a city career by cheating the system and, in doing so, he let down the expectations of the whole community," Steward said.

A spokeswoman for Schroders, one of Britain's largest investment managers, said the company had not been subject to any investigation and gave full co-operation to the FCA.

"Mr Clarke is no longer employed by Schroders, and these proceedings relate entirely to his personal actions. There is no indication of any detrimental impact on our clients or financial results," the spokeswoman said.

He pleaded guilty to insider trading in Swan Hill Group, Marlborough Stirling, Eidos, Neutec Pharma, Retail Decisions, Raven Mount Group, BSS Group, Autonomy Corp, and Invensys.

The trading took place between Oct. 30, 2003 and Nov. 28, 2012.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.